drugset / Trial / NCT03273387

The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension

NCT03273387

Phase 2/3 Completed 26 enrolled Indonesia University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study will evaluate the effect of trimetazidine versus placebo in addition to standard pulmonary arterial hypertension regime on right ventricular function in pulmonary arterial hypertension patients.

Timeline

Start
2017-09-10
Primary completion
2018-11-01
Completion
2018-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Trimetazidine Small molecule 35 mg